The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans.
Von Eschen K, Morrison R, Braun M, Ofori-Anyinam O, De Kock E, Pavithran P, Koutsoukos M, Moris P, Cain D, Dubois MC, Cohen J, Ballou WR.
Von Eschen K, et al. Among authors: moris p.
Hum Vaccin. 2009 Jul;5(7):475-82. doi: 10.4161/hv.8570. Epub 2009 Jul 27.
Hum Vaccin. 2009.
PMID: 19587528
Clinical Trial.